Company: HURA
Filing Date: 2025-05-06
Form Type: S-4/A
Source: 0001193125-25-113920
Chunk: 775

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-06
Form: S-4/A
Chunk 775
---
ing period of one year .

As of June 30, 2024, 4 RSU had vested and were converted to common shares, and 60 RSU had vested but were converted to common shares subsequent to June 30, 2024.

<div align='center'>F-23</div>

During the year ended June 30, 2024, the Company recognized a total of $ 171 (2023 - $ 90 ) related to RSU.

| Balance – June 30, 2022               |     | Number ofRSU(in thousands) |  — |   |
|:--------------------------------------|:----|:---------------------------|---:|:--|
| Issuance                              |     |                            | 78 |   |
| Balance – June 30, 2023               |     |                            | 78 |   |
| Vested and converted to common shares |     |                            | (4 | ) |
| Forfeited                             |     |                            | (8 | ) |
| Balance – June 30, 2024               |     |                            | 66 |   |

Common stock warrants

The following table sets forth changes in outstanding warrants:

| Balance – June 30, 2022                    
 Expiry of 2018 Investor and Agent warrants |     | Number ofwarrants(in thousands) | 720 
  (7 | ) |     | Weightedaverageexerciseprice$ |  49.36 
 625.68 |
|:-------------------------------------------|:----|:--------------------------------|----:|:--|:----|:------------------------------|-------:|
| Balance – June 30, 2023                    |     |                                 | 713 |   |     |                               |  43.55 |
| Expiry of warrants issued for services     |     |                                 | (20 | ) |     |                               |  71.53 |
| Expiry of 2019 Investor and Agent warrants |     |                                 | (16 | ) |     |                               | 157.25 |
| Balance – June 30, 2024                    |     |                                 | 677 |   |     |                               |  39.99 |

The following table summarizes the Company’s outstanding warrants as of June 30, 2024:

| Description of warrants      
 2022 April Investor warrants 
 2022 Investor warrants       |     | Number(in thousands) | 325 
 240 |     | Exerciseprice $ |